value-based pricing
Valuing medicines and NHS reform – the ABPI view
December 10, 2010Sales and Marketing ABPI, NHS reforms, Paul Catchpole, market access, value-based pricing
For those concerned with improving the value for money of medicines to the UK’s health service, the government’s White Paper …
UK pharma faces rising costs from value-based pricing
December 3, 2010Sales and Marketing Eli Lilly, VBP, lilly, value-based pricing
The government’s planned introduction of a value-based pricing system in the UK could increase costs and bureaucracy for the industry, …
Change is needed, concedes NICE chief, but defends record
November 30, 2010Sales and Marketing Andrew Dillon, NHS reform, NICE, cost-effectiveness, health technology assessment, hta, value-based pricing
The chief executive of NICE acknowledges changes are needed in how drugs are assessed in the UK – including more …
Value-based pricing no ‘magic bullet’ – ABPI
November 16, 2010Sales and Marketing ABPI, Dr Richard Barker, NHS drug sales, PPRS, UK medicines pricing, value-based pricing
UK pharma association the ABPI has warned that the government’s planned value-based pricing system for medicines will not necessarily save …
NICE ‘surprised’ at downgrading of its role
November 5, 2010Sales and Marketing Andrew Dillon, GP prescribing deicisions, NICE, QALY, incremental cost-effectiveness ratio, value-based pricing
NICE received no warning that its health technology assessment role is to be downgraded, the watchdog’s head has admitted. In …
£600m confirmed for three year Cancer Drugs Fund
October 27, 2010Sales and Marketing Cancer, Cancer Drugs Fund, NHS, NICE, cancer drugs, value-based pricing
The NHS will get the extra money it was promised to improve patient access to cancer medicines not backed by …
Minister confirms NICE will be sidelined in drug evaluation
October 26, 2010Sales and Marketing Andrew Lansley, Lord Howe, NICE, PPRS, medicines pricing, value-based pricing
A health minister has confirmed NICE will be “moved” from its current central role in health technology assessment to make …
PM hints pharma could avoid ‘value-based’ pricing
March 9, 2007Sales and Marketing PPRS, Tony Blair, value based pricing, value-based pricing
Tony Blair has suggested that the government will not accept value-based pricing of pharmaceutical products as proposed by the Office …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
